Pinderfields Hospital is an acute District General Hospital in Wakefield, West Yorkshire operated by the Mid Yorkshire Hospitals NHS Trust.

During the past decade, The Mid Yorkshire Hospitals NHS Trust conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 3 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 2 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Mid Yorkshire Hospitals NHS Trust" #1 sponsor was "Imperial College London" with 2 trials, followed by "Institute of Cancer Research, United Kingdom" with 2 trials sponsored, "Smith & Nephew, Inc." with 2 trials sponsored, "University of Leeds" with 2 trials sponsored and "Allergan" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Mid Yorkshire Hospitals NHS Trust" #1 collaborator was "Cambridge University Hospitals NHS Foundation Trust" with 3 trials as a collaborator, "Hull University Teaching Hospitals NHS Trust" with 3 trials as a collaborator, "Mid Yorkshire Hospitals NHS Trust" with 3 trials as a collaborator, "Barnsley Hospital NHS Foundation Trust" with 2 trials as a collaborator and "Oxford University Hospitals NHS Trust" with 2 trials as a collaborator. Other collaborators include 78 different institutions and companies that were collaborators in the rest 81 trials.

According to Clinical.Site data, the most researched conditions in "The Mid Yorkshire Hospitals NHS Trust" are "Breast Cancer" (3 trials), "Giant Cell Arteritis" (2 trials), "Acute Coronary Syndrome" (1 trials), "Allograft" (1 trials) and "Anterior Cruciate Ligament Injury" (1 trials). Many other conditions were trialed in "The Mid Yorkshire Hospitals NHS Trust" in a lesser frequency.

Most popular intervention types in "The Mid Yorkshire Hospitals NHS Trust" are "Drug" (10 trials), "Device" (5 trials), "Other" (4 trials), "Procedure" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "ACTICOAT" (1 trials), "AGI-1067" (1 trials), "Apixaban Oral Tablet" (1 trials), "Aromatase Inhibitors" (1 trials) and "Ascorbic Acid" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Mid Yorkshire Hospitals NHS Trust" are 21 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "The Mid Yorkshire Hospitals NHS Trust". undefined are not yet recruiting, 7 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in The Mid Yorkshire Hospitals NHS Trust, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in The Mid Yorkshire Hospitals NHS Trust, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 9 trials that are defined as “Not Applicable".